• Mutational Drivers and Drug Resistance in Multiple Myeloma C

  2026-04-21

  This study delivers the first comprehensive exome-wide characterization of 30 human multiple myeloma cell lines, revealing frequent and novel mutations that shape tumor progression and drug resistance. Its findings provide an essential resource for model selection and therapeutic research in multiple myeloma.

• MG-262 (Z-Leu-Leu-Leu-B(OH)2): Precision Tools for Unravelin

  2026-04-20

  Explore how MG-262 (Z-Leu-Leu-Leu-B(OH)2) enables advanced, mechanistically precise research into proteasome inhibition and skeletal muscle autophagy. This article uniquely bridges proteasome inhibitor applications with translational insights from recent muscle aging studies.

• Flumequine as a Quantitative Probe for DNA Topoisomerase II

  2026-04-20

  Explore Flumequine as a high-purity DNA topoisomerase II inhibitor for advanced DNA replication research. This article uniquely dissects quantitative assay strategies, mechanistic insights, and practical use cases, building upon current cancer drug response paradigms.

• SEMA3E Regulates Beige Adipocyte Thermogenesis via β-Catenin

  2026-04-19

  This study uncovers the role of SEMA3E in promoting beige adipocyte differentiation and thermogenesis through β-catenin signaling in mice. These findings provide mechanistic insights relevant to metabolic disease research and open paths to investigate the regulation of adipose tissue plasticity.

• Ferrostatin-1 (Fer-1): Precision Tool for Iron-Driven Cell D

  2026-04-18

  Explore how Ferrostatin-1 (Fer-1) empowers advanced ferroptosis and oxidative lipid damage inhibition research. This in-depth article uniquely connects molecular mechanism, experimental rigor, and the latest cancer biology insights.

• One-step TUNEL Cy5 Apoptosis Detection Kit: Advanced Use Cas

  2026-04-17

  The One-step TUNEL Cy5 Apoptosis Detection Kit offers precise, reliable quantification of programmed cell death in both tissue sections and cultured cells. Leveraging robust Cy5 fluorescence and a streamlined workflow, this kit empowers translational researchers to dissect apoptotic mechanisms and optimize experimental outcomes across disease models.

• Carbapenemase Genes in CREC: Dynamics and Resistance in Guan

  2026-04-16

  This study systematically characterizes carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China, revealing high prevalence, multidrug resistance, and efficient plasmid-mediated gene transfer. The findings inform antimicrobial resistance modeling, with direct implications for research on antimicrobial strategies and central nervous system infection models.

• PreScission Protease: Precision HRV 3C Protease for Protein

  2026-04-15

  PreScission Protease (PSP) stands out for its unmatched specificity in fusion protein tag removal at low temperatures, streamlining purification while preserving protein integrity. Its robust performance and compatibility with sensitive workflows make it indispensable for advanced molecular biology, chromatin, and condensate research.

• Circ_0001944 Modulates FXR/TLR4 and Ferroptosis in NiONP Fib

  2026-04-14

  This study elucidates how hsa_circ_0001944 regulates the FXR/TLR4 pathway and ferroptosis to mitigate collagen deposition induced by nickel oxide nanoparticles in hepatic stellate cells. The findings reveal a mechanistic link among non-coding RNA, nuclear receptor signaling, and cell death pathways in liver fibrosis, offering new perspectives for metabolic and fibrotic disease research.

• Radioiodinated Balsalazide Enables Selective UC Imaging in M

  2026-04-13

  This study introduces [125/131I]balsalazide as a highly selective radiotracer for imaging ulcerative colitis (UC) in murine models, demonstrating high labeling yield, radiochemical stability, and targeted biodistribution. The findings offer a robust tool for preclinical imaging research, highlighting improved specificity for UC lesions compared to previous radiotracers.

• Tamsulosin Reduces Postoperative Urinary Retention: Meta-Ana

  2026-04-13

  This systematic review and meta-analysis provides robust, quantitative evidence that Tamsulosin, a selective α1A-adrenergic receptor antagonist, significantly lowers the risk of postoperative urinary retention (POUR) and improves maximum urinary flow rate without increasing adverse events. The findings refine prior class-wide analyses by isolating (R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide as an effective, well-tolerated agent for POUR prevention, with direct translational implications for perioperative management.

• Flumequine: Optimizing DNA Topoisomerase II Inhibitor Assays

  2026-04-12

  Flumequine stands out as a high-purity DNA topoisomerase II inhibitor, enabling precise interrogation of DNA replication and repair pathways in cancer and resistance research. This article details robust workflows, troubleshooting tips, and evidence-driven enhancements for applied use in cell-based and biochemical assays.

• MK-1775: Wee1 Kinase Inhibitor Workflow for Sensitizing Tumo

  2026-04-12

  Leverage MK-1775, a highly selective Wee1 kinase inhibitor, to abrogate the G2 DNA damage checkpoint and sensitize p53-deficient tumor cells. This guide delivers stepwise protocols, troubleshooting insights, and a translation of cutting-edge in vitro drug response methods—empowering robust, reproducible cancer research.

• Phosphatase Inhibitor Cocktail 1: Elevating Phosphoproteomic

  2026-04-11

  APExBIO’s Phosphatase Inhibitor Cocktail 1 (100X in DMSO) redefines protein phosphorylation preservation, ensuring reliable, artifact-free analysis in signaling pathway research. Discover optimized workflows, key protocol parameters, and troubleshooting strategies that unlock next-generation phosphoproteomics and robust Western blot results.

• Reversine: Precision Aurora Kinase Inhibitor for Cancer Work

  2026-04-11

  Reversine empowers cancer researchers with targeted, reproducible Aurora kinase inhibition, delivering robust control over mitotic checkpoint signaling and apoptosis induction. This guide details in vitro and in vivo workflows, protocol refinements, and troubleshooting strategies to maximize the impact of Reversine in translational and mechanistic oncology research.

14996 records 1/1000 page Next 12345 下5页 Last page